Citations (418)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (38)
Hamzah Maswadeh, Arif Khan, Mohammed S. Alorainy, Naser A. Al-Wabel & Costas Demetzos. (2022) In vitro and in vivo activity of thermosensitive liposomes loaded with doxorubicin and cisplatin. Drug Development and Industrial Pharmacy 48:4, pages 158-168.
Read now
Read now
Mahmood Rasool, Arif Malik, Sulayman Waquar, Mahwish Arooj, Sara Zahid, Muhammad Asif, Sumaira Shaheen, Abrar Hussain, Hamid Ullah & Siew Hua Gan. (2022) New challenges in the use of nanomedicine in cancer therapy. Bioengineered 13:1, pages 759-773.
Read now
Read now
F Johannes P van Valenberg, Iris S G Brummelhuis, Lars H Lindner, Felix Kuhnle, Barbara Wedmann, Pascal Schweizer, Martin Hossann, J Alfred Witjes & Egbert Oosterwijk. (2021) DPPG2-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer. International Journal of Nanomedicine 16, pages 75-88.
Read now
Read now
Rajashekhar Kanchanapally, Sachin Kumar Deshmukh, Suhash Reddy Chavva, Nikhil Tyagi, Sanjeev Kumar Srivastava, Girijesh Kumar Patel, Ajay Pratap Singh & Seema Singh. (2019) Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis. International Journal of Nanomedicine 14, pages 531-541.
Read now
Read now
Qingxin Mu, Jesse Yu, Lisa A. McConnachie, John C. Kraft, Yu Gao, Gaurav K. Gulati & Rodney J. Y. Ho. (2018) Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook. Journal of Drug Targeting 26:5-6, pages 435-447.
Read now
Read now
Eshwaran Narayanan & Rajesh Wakaskar. (2018) Utilization of nanoparticulate therapy in cancer targeting. Cogent Medicine 5:1.
Read now
Read now
Anshita Gupta, Chanchal Deep Kaur, Shailendra Saraf & Swarnlata Saraf. (2017) Targeting of herbal bioactives through folate receptors: a novel concept to enhance intracellular drug delivery in cancer therapy. Journal of Receptors and Signal Transduction 37:3, pages 314-323.
Read now
Read now
Megan Grundy, Constantin Coussios & Robert Carlisle. (2016) Advances in systemic delivery of anti-cancer agents for the treatment of metastatic cancer. Expert Opinion on Drug Delivery 13:7, pages 999-1013.
Read now
Read now
Supandeep Singh Hallan, Prabhjot Kaur, Veerpal Kaur, Neeraj Mishra & Bhuvaneshwar Vaidya. (2016) Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery. Artificial Cells, Nanomedicine, and Biotechnology 44:1, pages 334-349.
Read now
Read now
Giuseppina Bozzuto & Agnese Molinari. (2015) Liposomes as nanomedical devices. International Journal of Nanomedicine 10, pages 975-999.
Read now
Read now
Salma E. Ahmed, Ana M. Martins & Ghaleb A. Husseini. (2015) The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes. Journal of Drug Targeting 23:1, pages 16-42.
Read now
Read now
Avital Stern, Matteo Guidotti, Eleonora Shaubi, Mary Popov, Charles Linder, Eliahu Heldman & Sarina Grinberg. (2014) Steric environment around acetylcholine head groups of bolaamphiphilic nanovesicles influences the release rate of encapsulated compounds. International Journal of Nanomedicine 9, pages 561-574.
Read now
Read now
Allison J Ambrosio, Daphne Suzin, Edwin L Palmer & Richard T Penson. (2014) Vintafolide (EC145) for the treatment of folate-receptor-α positive platinum-resistant ovarian cancer. Expert Review of Clinical Pharmacology 7:4, pages 443-450.
Read now
Read now
Francesco Trotta, Chiara Dianzani, Fabrizio Caldera, Barbara Mognetti & Roberta Cavalli. (2014) The application of nanosponges to cancer drug delivery. Expert Opinion on Drug Delivery 11:6, pages 931-941.
Read now
Read now
Sorin Emilian Leucuta. (2014) Subcellular drug targeting, pharmacokinetics and bioavailability. Journal of Drug Targeting 22:2, pages 95-115.
Read now
Read now
Stuart Ibsen, Carolyn E Schutt & Sadik Esener. (2013) Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment. Drug Design, Development and Therapy 7, pages 375-388.
Read now
Read now
Liang Wang & Zhong-Jun Xia. (2013) Combination of albumin-bound paclitaxel and pegylated liposomal doxorubicin is effective in treatment of heavily treated relapsed/refractory diffuse large B-cell lymphoma: a case report. Leukemia & Lymphoma 54:11, pages 2553-2555.
Read now
Read now
Sylvia A. Kuijpers, Maria J. Coimbra, Gert Storm & Raymond M. Schiffelers. (2010) Liposomes targeting tumour stromal cells. Molecular Membrane Biology 27:7, pages 328-340.
Read now
Read now
Avi Schroeder, Keren Turjeman, Josh E Schroeder, Meir Leibergall & Yechezkel Barenholz. (2010) Using liposomes to target infection and inflammation induced by foreign body injuries or medical implants. Expert Opinion on Drug Delivery 7:10, pages 1175-1189.
Read now
Read now
Jun Chen, Aihua Lin, Zhipeng Chen, Wei Wang, Ting Zhang, Hao Cai & Baochang Cai. (2010) Ammonium sulfate gradient loading of brucine into liposomes: effect of phospholipid composition on entrapment efficiency and physicochemical properties in vitro. Drug Development and Industrial Pharmacy 36:3, pages 245-253.
Read now
Read now
Thomas Kaasgaard & Thomas L Andresen. (2010) Liposomal cancer therapy: exploiting tumor characteristics. Expert Opinion on Drug Delivery 7:2, pages 225-243.
Read now
Read now
Ticha Limsuwan & Mariana C Castells. (2010) Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity. Expert Opinion on Drug Safety 9:1, pages 39-53.
Read now
Read now
Jolyon P Mitchell & Mark W Nagel. (2009) Oral inhalation therapy: meeting the challenge of developing more patient-appropriate devices. Expert Review of Medical Devices 6:2, pages 147-155.
Read now
Read now
Jörg Huwyler, Jürgen Drewe & Stephan Krähenbühl. (2008) Tumor targeting using liposomal antineoplastic drugs. International Journal of Nanomedicine 3:1, pages 21-29.
Read now
Read now
Vladimir Torchilin. (2008) Antibody-modified liposomes for cancer chemotherapy. Expert Opinion on Drug Delivery 5:9, pages 1003-1025.
Read now
Read now
Yongming Zhang, Aidong Li, Zheng Wang, Zhikai Han, Jie He & Jie Ma. (2008) Antimetastatic activities of pegylated liposomal doxorubicin in a murine metastatic lung cancer model. Journal of Drug Targeting 16:9, pages 679-687.
Read now
Read now
Irene Hl Hamelers & Anton Ipm de Kroon. (2007) Nanocapsules: A Novel Formulation Technology For Platinum-Based Anticancer Drugs. Future Lipidology 2:4, pages 445-453.
Read now
Read now
Khaled Greish. (2007) Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines. Journal of Drug Targeting 15:7-8, pages 457-464.
Read now
Read now
Ijeoma F Uchegbu. (2006) Pharmaceutical nanotechnology: polymeric vesicles for drug and gene delivery. Expert Opinion on Drug Delivery 3:5, pages 629-640.
Read now
Read now
Alberto A. Gabizon, Hilary Shmeeda & Samuel Zalipsky. (2006) Pros and Cons of the Liposome Platform in Cancer Drug Targeting. Journal of Liposome Research 16:3, pages 175-183.
Read now
Read now
Charles O Noble, Dmitri B Kirpotin, Mark E Hayes, Christoph Mamot, Keelung Hong, John W Park, Christopher C Benz, James D Marks & Daryl C Drummond. (2004) Development of ligand-targeted liposomes for cancer therapy. Expert Opinion on Therapeutic Targets 8:4, pages 335-353.
Read now
Read now
Alberto A. Gabizon, Olga Lyass, Gerald J. Berry & Mark Wildgust. (2004) Cardiac Safety of Pegylated Liposomal Doxorubicin (Doxil®/Caelyx®) Demonstrated by Endomyocardial Biopsy in Patients with Advanced Malignancies. Cancer Investigation 22:5, pages 663-669.
Read now
Read now
Manohar Ratnam, Hong Hao, Xuan Zheng, Hui Wang, Huiling Qi, Robert Lee & Xing Pan. (2003) Receptor induction and targeted drug delivery: a new antileukaemia strategy. Expert Opinion on Biological Therapy 3:4, pages 563-574.
Read now
Read now
Alberto Gabizon. (2003) Emerging Role of Liposomal Drug Carrier Systems in Cancer Chemotherapy. Journal of Liposome Research 13:1, pages 17-20.
Read now
Read now
Ta-Chung Chao, Wei-Shu Wang, Chueh-Chuan Yen, Tzeon-Jye Chiou, Jin-Hwang Liu & Po-Min Chen. (2003) A Dose-Escalating Pilot Study of Sterically Stabilized, Pegylated Liposomal Doxorubicin (Lipo-Dox®) in Patients with Metastatic Breast Cancer. Cancer Investigation 21:6, pages 837-847.
Read now
Read now
J. Szebeni, L. Baranyi, S. Savay, J. Milosevits, R. Bunger, P. Laverman, J. M. Metselaar, G. Storm, A. Chanan-Khan, L. Liebes, F. M. Muggia, R. Cohen, Y. Barenholz & C. R. Alving. (2002) ROLE OF COMPLEMENT ACTIVATION IN HYPERSENSITIVITY REACTIONS TO DOXIL AND HYNIC PEG LIPOSOMES: EXPERIMENTAL AND CLINICAL STUDIES. Journal of Liposome Research 12:1-2, pages 165-172.
Read now
Read now
Alejandra T. Perez, Gabriel H. Domenech, Cynthia Frankel & Charles L. Vogel. (2002) Pegylated Liposomal Doxorubicin (Doxil®) for Metastatic Breast Cancer: The Cancer Research Network, Inc., Experience. Cancer Investigation 20:sup2, pages 22-29.
Read now
Read now
Gilberte Marti-Mestres & Françoise Nielloud. (2002) Emulsions in Health Care Applications—An Overview. Journal of Dispersion Science and Technology 23:1-3, pages 419-439.
Read now
Read now
Articles from other publishers (380)
Lilian Saryeddine, Josh Hadnutt, Axelle Grélard, Estelle Morvan, Bruno Alies, Corinne Buré, Isabelle Bestel & Eduard Badarau. (2024) Design of light-responsive amphiphilic self-assemblies: A novel application of the photosensitive diazirine moiety. Journal of Colloid and Interface Science 653, pages 1792-1804.
Crossref
Crossref
Jagabandhu Bag, Sabyasachi Banerjee, Arnab De, Sreejan Manna, Subhasis Banerjee, S. K. Ashok Kumar & Sourav De. (2023) Nanoengineered approaches to improve the efficacy of targeted drug delivery for the treatment of malignancy: a comprehensive review. Future Journal of Pharmaceutical Sciences 9:1.
Crossref
Crossref
Tetiana Korzun, Abraham S. Moses, Parham Diba, Ariana L. Sattler, Brennan Olson, Olena R. Taratula, Tanja Pejovic, Daniel L. Marks & Oleh Taratula. (2023) Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers. Small.
Crossref
Crossref
Arvin Honari & Shashank R. Sirsi. (2023) The Evolution and Recent Trends in Acoustic Targeting of Encapsulated Drugs to Solid Tumors: Strategies beyond Sonoporation. Pharmaceutics 15:6, pages 1705.
Crossref
Crossref
Catherine B Goff & Constantin A Dasanu. (2023) Changing therapeutic landscape in advanced Kaposi sarcoma: Current state and future directions. Journal of Oncology Pharmacy Practice 29:4, pages 917-926.
Crossref
Crossref
Raghuraj Singh, Krishna Jadhav, Kalpesh Vaghasiya, Eupa Ray, Rahul Shukla & Rahul Kumar Verma. (2023) New Generation Smart Drug Delivery Systems for Rheumatoid Arthritis. Current Pharmaceutical Design 29:13, pages 984-1001.
Crossref
Crossref
Łukasz Kiraga, Paulina Kucharzewska, Damian Strzemecki, Tomasz P. Rygiel & Magdalena Król. (2023)
Non-radioactive imaging strategies for
in vivo
immune cell tracking
. Physical Sciences Reviews 8:3, pages 385-403.
Crossref
Crossref
Simranjeet KaurDilpreet Singh. (2023) A Sojourn on Liposomal Delivery System: Recent Advances and Future Prospects. ASSAY and Drug Development Technologies 21:2, pages 48-64.
Crossref
Crossref
Federica Foglietta, Manuela Macrì, Patrizia Panzanelli, Andrea Francovich, Gianni Durando, Francesca Garello, Enzo Terreno, Loredana Serpe & Roberto Canaparo. (2023) Ultrasound boosts doxorubicin efficacy against sensitive and resistant ovarian cancer cells. European Journal of Pharmaceutics and Biopharmaceutics 183, pages 119-131.
Crossref
Crossref
Olivia Young, Nealie Ngo, Leslie Lin, Laura Stanbery, Justin Fortune Creeden, Danae Hamouda & John Nemunaitis. (2023) Folate Receptor as a Biomarker and Therapeutic Target in Solid Tumors. Current Problems in Cancer 47:1, pages 100917.
Crossref
Crossref
Monu Kumar Shukla, Anik Kumar Das, Anshuman Gaurav, Dheeraj Bisht, Anita Singh & Deepak Kumar. 2023. Nanotechnology for Drug Delivery and Pharmaceuticals. Nanotechnology for Drug Delivery and Pharmaceuticals
187
206
.
Luciana B. Lopes, Alexsandra C. Apolinário, Giovanna C. Salata, Isabella D. Malagó & Julia S. Passos. 2023. Cancer Nanotechnology. Cancer Nanotechnology
3
44
.
Vera L. Kovalenko, Elena N. Komedchikova, Anna S. Sogomonyan, Ekaterina D. Tereshina, Olga A. Kolesnikova, Aziz B. Mirkasymov, Anna M. Iureva, Andrei V. Zvyagin, Petr I. Nikitin & Victoria O. Shipunova. (2022) Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo. Pharmaceutics 15:1, pages 92.
Crossref
Crossref
Isobel C Jones & Crispin R Dass. (2022) Doxorubicin-induced cardiotoxicity: causative factors and possible interventions. Journal of Pharmacy and Pharmacology 74:12, pages 1677-1688.
Crossref
Crossref
Supriya Mehta, Shweta Dumoga, Sahil Malhotra & Neetu Singh. (2022) Comparative analysis of PEG-liposomes and RBCs-derived nanovesicles for anti-tumor therapy. Colloids and Surfaces B: Biointerfaces 218, pages 112785.
Crossref
Crossref
Elidamar Nunes de Carvalho Lima, Guilherme Leão Barros Martins, Ricardo Sobhie Diaz, Mauro Schechter, José Roberto Castilho Piqueira & João Francisco Justo. (2022) Effects of Carbon Nanomaterials and Aloe vera on Melanomas—Where Are We? Recent Updates. Pharmaceutics 14:10, pages 2004.
Crossref
Crossref
Juan Liao, Yinyin Qian, Zhiya Sun, Jie Wang, Qiang Zhang, Qiying Zheng, Shiqi Wei, Nian Liu & Huaming Yang. (2022) In Vitro Binding and Release Mechanisms of Doxorubicin from Nanoclays. The Journal of Physical Chemistry Letters 13:36, pages 8429-8435.
Crossref
Crossref
Saba Dadpour, Amin Mehrabian, Mahdieh Arabsalmani, Elaheh Mirhadi, Anis Askarizadeh, Mohammad Mashreghi & Mahmoud Reza Jaafari. (2022) The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity. IET Nanobiotechnology 16:7-8, pages 259-272.
Crossref
Crossref
Yifan Cai, Jianping Qi, Yi Lu, Haisheng He & Wei Wu. (2022) The in vivo fate of polymeric micelles. Advanced Drug Delivery Reviews 188, pages 114463.
Crossref
Crossref
Haoqi Wang, Yuntao Li, Yixin Qi, Erbao Zhao, Xiangshun Kong, Chao Yang, Qiqi Yang, Chengyuan Zhang, Yueping Liu & Zhenchuan Song. (2022) Pegylated Liposomal Doxorubicin, Docetaxel, and Trastuzumab as Neoadjuvant Treatment for HER2-Positive Breast Cancer Patients: A Phase II and Biomarker Study. Frontiers in Oncology 12.
Crossref
Crossref
Shahid Ud Din Wani, Mohammad Ali, Mubashir Hussain Masoodi, Nisar Ahmad Khan, Mohammed Iqbal Zargar, Reyaz Hassan, Suhail Ahmad Mir, Surya Prakash Gautam, H V Gangadharappa & Riyaz Ali M. Osmani. (2022) A review on nanoparticles categorization, characterization and applications in drug delivery systems. Vibrational Spectroscopy 121, pages 103407.
Crossref
Crossref
Pinki Saini & Mazia Ahmed. 2022. Handbook of Research on Advanced Phytochemicals and Plant-Based Drug Discovery. Handbook of Research on Advanced Phytochemicals and Plant-Based Drug Discovery
496
520
.
Mojtaba Rostami, Alireza Badiei, Amir Mohammad Sorouri, Mahdi Fasihi-Ramandi, Mohammad Reza Ganjali, Mehdi Rahimi-Nasrabadi & Farhad Ahmadi. (2022) Cur-loaded magnetic ZnFe2O4@L-cysteine – Ox, N-rich mesoporous -gC3N4 nanocarriers as a targeted sonodynamic chemotherapeutic agent for enhanced tumor eradication. Surfaces and Interfaces 30, pages 101900.
Crossref
Crossref
Alexis Eras, Danna Castillo, Margarita Suárez, Nelson Santiago Vispo, Fernando Albericio & Hortensia Rodriguez. (2022) Chemical Conjugation in Drug Delivery Systems. Frontiers in Chemistry 10.
Crossref
Crossref
Riya Khetan, Cintya Dharmayanti, Todd A. Gillam, Eric Kübler, Manuela Klingler-Hoffmann, Carmela Ricciardelli, Martin K. Oehler, Anton Blencowe, Sanjay Garg & Hugo Albrecht. (2022) Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines. Cancers 14:10, pages 2362.
Crossref
Crossref
Niloufar Rahiman, Marzieh Mohammadi, Seyedeh Hoda Alavizadeh, Leila Arabi, Ali Badiee & Mahmoud Reza Jaafari. (2022) Recent advancements in nanoparticle-mediated approaches for restoration of multiple sclerosis. Journal of Controlled Release 343, pages 620-644.
Crossref
Crossref
Natália A. D'Angelo, Mariana A. Noronha, Mayra C.C. Câmara, Isabelle S. Kurnik, Chuying Feng, Victor H.S. Araujo, João H.P.M. Santos, Valker Feitosa, João V.D. Molino, Carlota O. Rangel-Yagui, Marlus Chorilli, Emmanuel A. Ho & André M. Lopes. (2022) Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years. Biomaterials Advances 133, pages 112623.
Crossref
Crossref
Catherine B. Goff, Ann Stapleton, David M. Aboulafia & Constantin A. Dasanu. (2022) Necrotizing leg gangrene from invasive cutaneous Kaposi sarcoma, reversed by pegylated liposomal doxorubicin. Journal of Oncology Pharmacy Practice, pages 107815522110735.
Crossref
Crossref
Soumya S. Panda, Hemlata Das, Saroj Prasad Panda, Spoorthy Kolluri & Sindhu Kilaru. 2022. Advanced Nanomaterials for Point of Care Diagnosis and Therapy. Advanced Nanomaterials for Point of Care Diagnosis and Therapy
359
382
.
Adib H. Chisty & Mohammed Mizanur Rahman. 2022. Nanoscale Engineering of Biomaterials: Properties and Applications. Nanoscale Engineering of Biomaterials: Properties and Applications
619
648
.
Kylie Klein, Mary Dandulakis & Dana M. Roque. 2022. Advances in Diagnosis and Management of Ovarian Cancer. Advances in Diagnosis and Management of Ovarian Cancer
129
169
.
Yinan Ding, Rui Yang, Weiping Yu, Chunmei Hu, Zhiyuan Zhang, Dongfang Liu, Yanli An, Xihui Wang, Chen He, Peidang Liu, Qiusha Tang & Daozhen Chen. (2021) Chitosan oligosaccharide decorated liposomes combined with TH302 for photodynamic therapy in triple negative breast cancer. Journal of Nanobiotechnology 19:1.
Crossref
Crossref
Magdalena Kowalska, Marcin Broniatowski, Marzena Mach, Łukasz Płachta & Paweł Wydro. (2021) Effect of lipopolymer (DSPE-PEG750) on phospholipid monolayers and bilayers differing in the structure of the polar head group. Journal of Molecular Liquids 344, pages 117715.
Crossref
Crossref
Swati Sharma, Roza Parveen & Biswa Prasun Chatterji. (2021) Toxicology of Nanoparticles in Drug Delivery. Current Pathobiology Reports 9:4, pages 133-144.
Crossref
Crossref
Jenny Ling-Yu Chen, Chun-Kai Pan, Yu-Li Lin, Ching-Yi Tsai, Yu-Sen Huang, Wen-Chi Yang, Feng-Ming Hsu, Sung-Hsin Kuo & Ming-Jium Shieh. (2021) Preclinical evaluation of PEGylated liposomal doxorubicin as an effective radiosensitizer in chemoradiotherapy for lung cancer. Strahlentherapie und Onkologie 197:12, pages 1131-1142.
Crossref
Crossref
Wei He, Yawei Du, Tao Wang, Ji Wang, Lei Cheng & Xinsong Li. (2021) Dimeric Artesunate–Phosphatidylcholine-Based Liposomes for Irinotecan Delivery as a Combination Therapy Approach. Molecular Pharmaceutics 18:10, pages 3862-3870.
Crossref
Crossref
Mojtaba Rostami, Ali Sobhani Nasab, Mahdi Fasihi-Ramandi, Alireza Badiei, Mohammad Reza Ganjali, Mehdi Rahimi-Nasrabadi & Farhad Ahmadi. (2021) Cur-loaded magnetic ZnFe2O4@mZnO-Ox-p-g-C3N4 composites as dual pH- and ultrasound responsive nano-carriers for controlled and targeted cancer chemotherapy. Materials Chemistry and Physics 271, pages 124863.
Crossref
Crossref
Yehia Saleh, Ola Abdelkarim, Khader Herzallah & George S. Abela. (2020) Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment. Heart Failure Reviews 26:5, pages 1159-1173.
Crossref
Crossref
Wyatt M. Becicka, Peter A. Bielecki, Morgan E. Lorkowski, Taylor J. Moon, Yahan Zhang, Prabhani U. Atukorale, Gil Covarrubias & Efstathios Karathanasis. (2021) The effect of PEGylation on the efficacy and uptake of an immunostimulatory nanoparticle in the tumor immune microenvironment. Nanoscale Advances 3:17, pages 4961-4972.
Crossref
Crossref
Yanjia Yu, Mohan Dai, Wei Xu, Shuangshuang Chen & Qinghua Lu. (2021) Close to Real: Large‐Volume 3D Cell Spheroids on a Superamphiphobic Surface. Advanced Materials Interfaces 8:9.
Crossref
Crossref
Yih Rue Ong, Robert De Rose & Angus P. R. Johnston. (2021) In Vivo Quantification of Nanoparticle Association with Immune Cell Subsets in Blood. Advanced Healthcare Materials 10:9.
Crossref
Crossref
Fatima El Hajj, Patrick F. J. Fuchs, Wladimir Urbach, Mohammad Nassereddine, Salah Hamieh & Nicolas Taulier. (2021) Molecular Study of Ultrasound-Triggered Release of Fluorescein from Liposomes. Langmuir 37:13, pages 3868-3881.
Crossref
Crossref
Hui Yu, Yining Qiu, Hui Yu, Zhujun Wang, Jiawei Xu, Yun Peng, Xia Wan, Xiaoyan Wu, Runming Jin & Fen Zhou. (2021) Anthracycline Induced Cardiac Disorders in Childhood Acute Lymphoblastic Leukemia: A Single-Centre, Retrospective, Observational Study. Frontiers in Pharmacology 12.
Crossref
Crossref
Shailaja Dombe & Pramodkumar Shirote. (2021) Nanosponges Encapsulated Phytochemicals for Targeting Cancer: A Review. Current Drug Targets 22:4, pages 443-462.
Crossref
Crossref
Andrew Pradeep, R. Sethu Nagarajan & H. Fazil. 2021. Handbook of Research on Nano-Strategies for Combatting Antimicrobial Resistance and Cancer. Handbook of Research on Nano-Strategies for Combatting Antimicrobial Resistance and Cancer
294
305
.
Kai-Ping Zhang, Xiang Fang, Yin Zhang & Min Chao. (2021) The prognosis of cancer patients undergoing liposomal doxorubicin-based chemotherapy. Medicine 100:34, pages e26690.
Crossref
Crossref
Heegon Kim, Hyeonjeong Han, Moonkyoung Jeong, Junhee Han & Ji-Ho Park. (2021) Management of lymph node metastasis via local chemotherapy can prevent distant metastasis and improve survival in mice. Journal of Controlled Release 329, pages 847-857.
Crossref
Crossref
R.J.A. Vibhavari, Gautam Kumar, Vanishree Rao, Sri Pragnya Cheruku & Nitesh Kumar. 2021. Nano-Pharmacokinetics and Theranostics. Nano-Pharmacokinetics and Theranostics
117
152
.
Lawrence A. Mark, John A. Zic & Gabrielle-Eugenie Duprat. 2021. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy
405
418.e3
.
R. Ilangovan, V. Subha, R.S. Earnest Ravindran, S. Kirubanandan & S. Renganathan. 2021. Nanoscale Processing. Nanoscale Processing
33
70
.
Ashwini S. Shinde, Pallavi S. Shinde & Tuhin S. Santra. 2021. Nanomaterials and Their Biomedical Applications. Nanomaterials and Their Biomedical Applications
253
296
.
Daniel C. Pan, Vinu Krishnan, Alyssa K. Salinas, Jayoung Kim, Tao Sun, Sagi Ravid, Kevin Peng, Debra Wu, Md Nurunnabi, Jeffery A. Nelson, Zachary Niziolek, Junling Guo & Samir Mitragotri. (2020)
Hyaluronic a
cid–doxorubicin
nanoparticles for targeted treatment of colorectal cancer
. Bioengineering & Translational Medicine 6:1.
Crossref
Crossref
Edward L Coleridge & Katherine E Dunn. (2020) Assessing the cost-effectiveness of DNA origami nanostructures for targeted delivery of anti-cancer drugs to tumours. Biomedical Physics & Engineering Express 6:6, pages 065030.
Crossref
Crossref
Karim Dadashi Noshahr, Fahimeh Shamsi, Peter Valtchev, Parviz Kokhaei, Maral Hemati, Mohammad Reza Akbari Eidgahi & Ali Khaleghian. (2020) Optimization of post-insertion method to conjugate Doxil with anti-CD133 monoclonal antibodies: Investigating the specific binding and cytotoxicity to colorectal cancer cells in vitro. Saudi Pharmaceutical Journal 28:11, pages 1392-1401.
Crossref
Crossref
Stanislav Filip, Ondřej Kubeček, Jiří Špaček, Miriam Lánská & Milan Bláha. (2020) Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years. Pharmaceutics 12:10, pages 940.
Crossref
Crossref
Yang Shi. (2020) Clinical Translation of Nanomedicine and Biomaterials for Cancer Immunotherapy: Progress and Perspectives. Advanced Therapeutics 3:9.
Crossref
Crossref
Ke-Tao Jin, Ze-Bei Lu, Jin-Yang Chen, Yu-Yao Liu, Huan-Rong Lan, Hai-Ying Dong, Fan Yang, Yuan-Yuan Zhao & Xiao-Yi Chen. (2020) Recent Trends in Nanocarrier-Based Targeted Chemotherapy: Selective Delivery of Anticancer Drugs for Effective Lung, Colon, Cervical, and Breast Cancer Treatment. Journal of Nanomaterials 2020, pages 1-14.
Crossref
Crossref
Daria Tretiakova, Elena Svirshchevskaya, Natalia Onishchenko, Anna Alekseeva, Ivan Boldyrev, Roman Kamyshinsky, Alexey Natykan, Anton Lokhmotov, Diana Arantseva, Dmitry Shobolov & Elena Vodovozova. (2020) Liposomal Formulation of a Melphalan Lipophilic Prodrug: Studies of Acute Toxicity, Tolerability, and Antitumor Efficacy. Current Drug Delivery 17:4, pages 312-323.
Crossref
Crossref
David Dahlgren & Hans Lennernäs. (2020) Antibody-Drug Conjugates and Targeted Treatment Strategies for Hepatocellular Carcinoma: A Drug-Delivery Perspective. Molecules 25:12, pages 2861.
Crossref
Crossref
Naseem Akhtar, Salman AA Mohammed, Varsha Singh, Ahmed AH Abdellatif, Hamdoon A Mohammad, Abdul Ahad, Mohammad Yusuf, Habeeb Khadri, Mamuna Naz, Omar Khan, Mohammad Rashid & Riaz A Khan. (2020) Liposome-based drug delivery of various anticancer agents of synthetic and natural product origin: a patent overview. Pharmaceutical Patent Analyst 9:3, pages 87-116.
Crossref
Crossref
Wabel AL-Busairi & Maitham Khajah. 2020. Tumor Progression and Metastasis. Tumor Progression and Metastasis.
Suraj Baskararaj, Theivendren Panneerselvam, Saravanan Govindaraj, Sankarganesh Arunachalam, Pavadai Parasuraman, Sureshbabu Ram Kumar Pandian, Murugesan Sankaranarayanan, Uma Priya Mohan, Ponnusamy Palanisamy, Vigneshwaran Ravishankar & Selvaraj Kunjiappan. (2020) Formulation and characterization of folate receptor-targeted PEGylated liposome encapsulating bioactive compounds from Kappaphycus alvarezii for cancer therapy. 3 Biotech 10:3.
Crossref
Crossref
Tracy Stokol, Chris Wan, Robert Blakely, Vanessa Bellat & Benedict Law. (2020) Aldoxorubicin-loaded nanofibers are cytotoxic for canine mammary carcinoma and osteosarcoma cell lines in vitro: A short communication. Research in Veterinary Science 128, pages 86-89.
Crossref
Crossref
Ondřej Kubeček, Jiřina Martínková, Jaroslav Chládek, Milan Bláha, Jana Maláková, Miroslav Hodek, Jiří Špaček & Stanislav Filip. (2019) Plasmafiltration as an effective method in the removal of circulating pegylated liposomal doxorubicin (PLD) and the reduction of mucocutaneous toxicity during the treatment of advanced platinum-resistant ovarian cancer. Cancer Chemotherapy and Pharmacology 85:2, pages 353-365.
Crossref
Crossref
Alberto A. Gabizon, Rafael T.M. de Rosales & Ninh M. La-Beck. (2020) Translational considerations in nanomedicine: The oncology perspective. Advanced Drug Delivery Reviews 158, pages 140-157.
Crossref
Crossref
Arjun Khunger & Bassam Estfan. 2020. Handbook of Cancer Treatment-Related Symptons and Toxicities. Handbook of Cancer Treatment-Related Symptons and Toxicities
93
106
.
Suzana Aulic, Domenico Marson, Erik Laurini, Maurizio Fermeglia & Sabrina Pricl. 2020. Nanomedicines for Breast Cancer Theranostics. Nanomedicines for Breast Cancer Theranostics
371
404
.
Sonali S. Rohiwal & Arpita Pandey Tiwari. 2020. Nanomedicines for Breast Cancer Theranostics. Nanomedicines for Breast Cancer Theranostics
331
349
.
Vijay Kumar, Jagat R. Kanwar & Anita Kamra Verma. 2020. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents
481
507
.
Heyam Saad Ali, Babiker M. El-Haj, Salim Saifullah & Muhammad Kawish. 2020. Metal Nanoparticles for Drug Delivery and Diagnostic Applications. Metal Nanoparticles for Drug Delivery and Diagnostic Applications
43
58
.
Nur Hulwani Md Saari & Lee Suan Chua. 2020. Nanoengineering in the Beverage Industry. Nanoengineering in the Beverage Industry
405
436
.
Surendra Tripathy, Roohi Kesharwani, Dilip Kumar Patel & Malay K. Das. 2020. Nano Medicine and Nano Safety. Nano Medicine and Nano Safety
289
311
.
Brahmeshwar Mishra, Mansi Upadhyay & Bharti Bakde. 2020. Interpenetrating Polymer Network: Biomedical Applications. Interpenetrating Polymer Network: Biomedical Applications
119
141
.
Yanqi Zhang, Limin Zhang, Guoyan Yin, Wenjuan Ma, Jiao Li, Zhongxing Zhou & Feng Gao. (2019) In Vivo Pharmacokinetics Assessment of Indocyanine Green-Loaded Nanoparticles in Tumor Tissue with a Dynamic Diffuse Fluorescence Tomography System. Molecular Imaging and Biology 21:6, pages 1044-1053.
Crossref
Crossref
Claudia Weber, Matthias Voigt, Johanna Simon, Ann-Kathrin Danner, Holger Frey, Volker Mailänder, Mark Helm, Svenja Morsbach & Katharina Landfester. (2019) Functionalization of Liposomes with Hydrophilic Polymers Results in Macrophage Uptake Independent of the Protein Corona. Biomacromolecules 20:8, pages 2989-2999.
Crossref
Crossref
Pal Patel, Nikita Meghani, Krupa Kansara & Ashutosh Kumar. (2019) Nanotherapeutics for the Treatment of Cancer and Arthritis. Current Drug Metabolism 20:6, pages 430-445.
Crossref
Crossref
Sara Emad El-Agamy, Amal Kamal Abdel-Aziz, Ahmed Esmat & Samar S. Azab. (2019) Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain. Cancer Chemotherapy and Pharmacology 84:1, pages 1-14.
Crossref
Crossref
Manuela Robella, Marco Vaira, Monica Argenziano, Rita Spagnolo, Roberta Cavalli, Alice Borsano, Sergio Gentilli & Michele De Simone. (2019) Exploring the Use of Pegylated Liposomal Doxorubicin (Caelyx®) as Pressurized Intraperitoneal Aerosol Chemotherapy. Frontiers in Pharmacology 10.
Crossref
Crossref
Prashant Dogra, Joseph D. Butner, Yao-li Chuang, Sergio Caserta, Shreya Goel, C. Jeffrey Brinker, Vittorio Cristini & Zhihui Wang. (2019) Mathematical modeling in cancer nanomedicine: a review. Biomedical Microdevices 21:2.
Crossref
Crossref
Geoffrey Gifford, Vivian P. Vu, Nirmal K. Banda, V. Michael Holers, Guankui Wang, Ernest V. Groman, Donald Backos, Robert Scheinman, S. Moein Moghimi & Dmitri Simberg. (2019) Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55. Journal of Controlled Release 302, pages 181-189.
Crossref
Crossref
Li Chen, Hamad Alrbyawi, Ishwor Poudel, Robert D. Arnold & R. Jayachandra Babu. (2019) Co-delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines. AAPS PharmSciTech 20:3.
Crossref
Crossref
Mehran Alavi & Mehrdad Hamidi. (2019) Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles. Drug Metabolism and Personalized Therapy 34:1.
Crossref
Crossref
Kevin A. Carter, Dandan Luo, Jumin Geng, Stephan T. Stern & Jonathan F. Lovell. (2019) Blood Interactions, Pharmacokinetics, and Depth-Dependent Ablation of Rat Mammary Tumors with Photoactivatable, Liposomal Doxorubicin. Molecular Cancer Therapeutics 18:3, pages 592-601.
Crossref
Crossref
Gizem Bor, Intan Diana Mat Azmi & Anan Yaghmur. (2019) Nanomedicines for cancer therapy: current status, challenges and future prospects. Therapeutic Delivery 10:2, pages 113-132.
Crossref
Crossref
Nagina Belali, Nasrul Wathoni & Muchtaridi Muchtaridi. (2019) Advances in orally targeted drug delivery to colon. Journal of Advanced Pharmaceutical Technology & Research 10:3, pages 100.
Crossref
Crossref
Victor Sebastian & Manuel Arruebo. 2019. Microfluidics for Pharmaceutical Applications. Microfluidics for Pharmaceutical Applications
179
216
.
Nazish Tabassum, Vinod Verma, Manoj Kumar, Ashok Kumar & Birbal Singh. (2018) Nanomedicine in cancer stem cell therapy: from fringe to forefront. Cell and Tissue Research 374:3, pages 427-438.
Crossref
Crossref
Merari T Chevalier, Juan Garona, Natasha T Sobol, Hernan G Farina, Daniel F Alonso & Vera A Álvarez. (2018)
In vitro
and
in vivo
evaluation of desmopressin-loaded poly(
D,L
-lactic-co-glycolic acid) nanoparticles for its potential use in cancer treatment
. Nanomedicine 13:22, pages 2835-2849.
Crossref
Crossref
Pawel Robak, Izabela Drozdz, Janusz Szemraj & Tadeusz Robak. (2018) Drug resistance in multiple myeloma. Cancer Treatment Reviews 70, pages 199-208.
Crossref
Crossref
Shahzeb Khan, Muhammad Imran, Tariq Tahir Butt, Syed Wadood Ali Shah, Muhammad Sohail, Arif Malik, Srijit Das, Hnin Ei Thu, Aishah Adam & Zahid Hussain. (2018) Curcumin based nanomedicines as efficient nanoplatform for treatment of cancer: New developments in reversing cancer drug resistance, rapid internalization, and improved anticancer efficacy. Trends in Food Science & Technology 80, pages 8-22.
Crossref
Crossref
Juliana de Oliveira Silva, Sued Eustáquio Mendes Miranda, Elaine Amaral Leite, Adriano de Paula Sabino, Karina Braga Gomes Borges, Valbert Nascimento Cardoso, Geovanni Dantas Cassali, Andrea Grabe Guimarães, Mônica Cristina Oliveira & André Luis Branco de Barros. (2018) Toxicological study of a new doxorubicin-loaded pH-sensitive liposome: A preclinical approach. Toxicology and Applied Pharmacology 352, pages 162-169.
Crossref
Crossref
Xiang Luo, Mingqi Liu, Ling Hu, Qiujun Qiu, Xinrong Liu, Cong Li, Mei Lu, Yang Liu, Ting Zhang, Songlei Zhou, David Julian McClements, Xian Jia, Yihui Deng & Yanzhi Song. (2018) Targeted delivery of pixantrone to neutrophils by poly(sialic acid)-p-octadecylamine conjugate modified liposomes with improved antitumor activity. International Journal of Pharmaceutics 547:1-2, pages 315-329.
Crossref
Crossref
Senthil Rajappa, Ashish Joshi, Dinesh Doval, Ullas Batra, Rejiv Rajendranath, Avinash Deo, Ghanshyam Biswas, Peush Bajpai, T. Tilak, Sriram Kane, Kishore Kumar, Manish Kumar, Avinash Talele, Prakash Devde, Ashutosh Gupta, Nisarg Joshi, Jaykumar Sejpal, Deepak Bunger & Mujtaba Khan. (2018) [Experts' Opinion] Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer. Oncology Letters.
Crossref
Crossref
Lauren D Field, Okhil K Nag, Ajmeeta Sangtani, Kelly E Burns & James B Delehanty. (2018) The role of nanoparticles in the improvement of systemic anticancer drug delivery. Therapeutic Delivery 9:7, pages 527-545.
Crossref
Crossref
Michael R. McDevitt, George Sgouros & Stavroula Sofou. (2018) Targeted and Nontargeted α-Particle Therapies. Annual Review of Biomedical Engineering 20:1, pages 73-93.
Crossref
Crossref
Peter A Henriksen. (2018) Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention. Heart 104:12, pages 971-977.
Crossref
Crossref
Fu Ou Yang, Nicholas C. Hsu, Sin-Hua Moi, Yin-Che Lu, Chia-Ming Hsieh, King-Jen Chang, Dar-Ren Chen, Chi-Wen Tu, Hwei-Chung Wang & Ming-Feng Hou. (2018) Efficacy and toxicity of pegylated liposomal doxorubicin-based chemotherapy in early-stage breast cancer: a multicenter retrospective case-control study. Asia-Pacific Journal of Clinical Oncology 14:3, pages 198-203.
Crossref
Crossref
Beatrice Casadei, Cinzia Pellegrini, Lorenzo Tonialini, Lisa Argnani & Pier Luigi Zinzani. (2018) Interesting activity of pegylated liposomal doxorubicin in primary refractory and multirelapsed Hodgkin lymphoma patients: bridge to transplant. Hematological Oncology 36:2, pages 489-491.
Crossref
Crossref
Chi-Feng Huang, Keng S. Liang, Tsui-Ling Hsu, Tsung-Tse Lee, Yi-Yun Chen, Shun-Min Yang, Hsiang-Hsin Chen, Shih-Hsin Huang, Wei-Hau Chang, Ting-Kuo Lee, Peilin Chen, Kuei-En Peng, Chien-Chun Chen, Cheng-Zhi Shi, Yu-Fang Hu, Giorgio Margaritondo, Tetsuya Ishikawa, Chi-Huey Wong & Y. Hwu. (2018) Free-electron-laser coherent diffraction images of individual drug-carrying liposome particles in solution. Nanoscale 10:6, pages 2820-2824.
Crossref
Crossref
Riyaz Ali M. Osmani, Parthasarathi K. Kulkarni, Vishakante Gowda, Umme Hani, Vishal K. Gupta, Madesh Prerana & Chandani Saha. 2018. Applications of Nanocomposite Materials in Drug Delivery. Applications of Nanocomposite Materials in Drug Delivery
97
147
.
Riyaz Ali Osmani, Parthasarathi Kulkarni, Shringari Manjunatha, Rudra Vaghela & Rohit Bhosale. 2018. Organic Materials as Smart Nanocarriers for Drug Delivery. Organic Materials as Smart Nanocarriers for Drug Delivery
659
717
.
Riyaz Ali Osmani, Parthasarathi Kulkarni, Shringari Manjunatha, Vishakante Gowda, Umme Hani, Rudra Vaghela & Rohit Bhosale. 2018. Environmental Nanotechnology. Environmental Nanotechnology
279
342
.
Halli Benasutti, Guankui Wang, Vivian P. Vu, Robert Scheinman, Ernest Groman, Laura Saba & Dmitri Simberg. (2017) Variability of Complement Response toward Preclinical and Clinical Nanocarriers in the General Population. Bioconjugate Chemistry 28:11, pages 2747-2755.
Crossref
Crossref
Sahar Amiri & Sanam Amiri. 2017. Cyclodextrins. Cyclodextrins
201
238
.
Carolyn Schutt, Stuart Ibsen, Eran Zahavy, Santosh Aryal, Stacey Kuo, Selin Esener, Michael Berns & Sadik Esener. (2017) Drug Delivery Nanoparticles with Locally Tunable Toxicity Made Entirely from a Light-Activatable Prodrug of Doxorubicin. Pharmaceutical Research 34:10, pages 2025-2035.
Crossref
Crossref
Anna Scomparin, Helena F. Florindo, Galia Tiram, Elaine L. Ferguson & Ronit Satchi-Fainaro. (2017) Two-step polymer- and liposome-enzyme prodrug therapies for cancer: PDEPT and PELT concepts and future perspectives. Advanced Drug Delivery Reviews 118, pages 52-64.
Crossref
Crossref
Kamal Razavi-Azarkhiavi, Mahmoud Reza Jaafari, Khalil Abnous, Bibi Marjan Razavi, Amir Hossein Jafarian, Faezeh Vahdati Hassani, Kobra Shirani & Gholamreza Karimi. (2017) The Cardiotoxic Mechanism of Doxorubicin (DOX) and Pegylated Liposomal DOX in Mice Bearing C-26 Colon Carcinoma: a Study Focused on microRNA Role for Toxicity Assessment of New Formulations. Pharmaceutical Research 34:9, pages 1849-1856.
Crossref
Crossref
Damián A. Grillo, Juan M. R. Albano, Esteban E. Mocskos, Julio C. Facelli, Mónica Pickholz & Marta B. Ferraro. (2017) Diblock copolymer bilayers as model for polymersomes: A coarse grain approach. The Journal of Chemical Physics 146:24.
Crossref
Crossref
Emma Kipps, Kate Young & Naureen Starling. (2017) Liposomal irinotecan in gemcitabine-refractory metastatic pancreatic cancer: efficacy, safety and place in therapy. Therapeutic Advances in Medical Oncology 9:3, pages 159-170.
Crossref
Crossref
Pik-Ling Lam, Wai-Yeung Wong, Zhaoxiang Bian, Chung-Hin Chui & Roberto Gambari. (2017) Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern. Nanomedicine 12:4, pages 357-385.
Crossref
Crossref
M. Vaccaro, M. Santarpia, G. Calapai, C. Mannucci, F. Borgia, G. Altavilla & S.P. Cannavò. (2016) Mucocutaneous toxicity induced by pegylated liposomal doxorubicin: a single‐institution, retrospective case series. British Journal of Dermatology 176:2, pages 507-509.
Crossref
Crossref
Luciana Giodini, Francesco Lo Re, Davide Campagnol, Elena Marangon, Bianca Posocco, Eva Dreussi & Giuseppe Toffoli. (2017) Nanocarriers in cancer clinical practice: a pharmacokinetic issue. Nanomedicine: Nanotechnology, Biology and Medicine 13:2, pages 583-599.
Crossref
Crossref
Amr Selim Abu Lila & Tatsuhiro Ishida. (2017) Liposomal Delivery Systems: Design Optimization and Current Applications. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 40:1, pages 1-10.
Crossref
Crossref
Wenmin Yuan, Rui Kuai, Zhipeng Dai, Yue Yuan, Nan Zheng, Wenlei Jiang, Charles Noble, Mark Hayes, Francis C. Szoka & Anna Schwendeman. (2016) Development of a Flow-Through USP-4 Apparatus Drug Release Assay to Evaluate Doxorubicin Liposomes. The AAPS Journal 19:1, pages 150-160.
Crossref
Crossref
Lulu Wang, Amyn A. Habib, Akiva Mintz, King C. Li & Dawen Zhao. (2017) Phosphatidylserine-Targeted Nanotheranostics for Brain Tumor Imaging and Therapeutic Potential. Molecular Imaging 16, pages 153601211770872.
Crossref
Crossref
Qin Wang & Xun Sun. (2017) Recent advances in nanomedicines for the treatment of rheumatoid arthritis. Biomaterials Science 5:8, pages 1407-1420.
Crossref
Crossref
Muhammad Raza Shah, Muhammad Imran & Shafi Ullah. 2017. Lipid-Based Nanocarriers for Drug Delivery and Diagnosis. Lipid-Based Nanocarriers for Drug Delivery and Diagnosis
219
238
.
Muhammad Raza Shah, Muhammad Imran & Shafi Ullah. 2017. Lipid-Based Nanocarriers for Drug Delivery and Diagnosis. Lipid-Based Nanocarriers for Drug Delivery and Diagnosis
191
218
.
T. Brabb & P.T. Tinkey. 2017. Patient Derived Tumor Xenograft Models. Patient Derived Tumor Xenograft Models
173
185
.
A.A. Mortlock, D.M. Wilson, J.G. Kettle, F.W. Goldberg & K.M. Foote. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
39
75
.
Wei Guo, Lu Xie & Jie Xu. 2017. Sarcoma. Sarcoma
561
571
.
Liecheng Yang, Xiaoyan Zhong, Qian Li, Xihui Zhang, Yangyun Wang, Kai Yang & Leshuai W. Zhang. (2016)
Potentiation of Drug-Induced Phospholipidosis
In Vitro
through PEGlyated Graphene Oxide as the Nanocarrier
. Toxicological Sciences, pages kfw233.
Crossref
Crossref
Joel G. Turner, Jana L. Dawson, Steven Grant, Kenneth H. Shain, William S. Dalton, Yun Dai, Mark Meads, Rachid Baz, Michael Kauffman, Sharon Shacham & Daniel M. Sullivan. (2016) Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors. Journal of Hematology & Oncology 9:1.
Crossref
Crossref
Friedrich Foerster, Denise Bamberger, Jonathan Schupp, Martin Weilbächer, Leonard Kaps, Stephanie Strobl, Lydia Radi, Mustafa Diken, Dennis Strand, Andrea Tuettenberg, Peter R Wich & Detlef Schuppan. (2016) Dextran-based therapeutic nanoparticles for hepatic drug delivery. Nanomedicine 11:20, pages 2663-2677.
Crossref
Crossref
Alejandro Sosnik. (2016) Drug self-assembly: A phenomenon at the nanometer scale with major impact in the structure–biological properties relationship and the treatment of disease. Progress in Materials Science 82, pages 39-82.
Crossref
Crossref
Anita K. Bakrania, Bhavesh C. Variya & Snehal S. Patel. (2016) Novel targets for paclitaxel nano formulations: Hopes and hypes in triple negative breast cancer. Pharmacological Research 111, pages 577-591.
Crossref
Crossref
Adam K. Brys, Raghavendra Gowda, Daniel B. Loriaux, Gavin P. Robertson & Paul J. Mosca. (2016) Nanotechnology-based strategies for combating toxicity and resistance in melanoma therapy. Biotechnology Advances 34:5, pages 565-577.
Crossref
Crossref
Vimala N. Bharadwaj, Jonathan Lifshitz, P. David Adelson, Vikram D. Kodibagkar & Sarah E. Stabenfeldt. (2016) Temporal assessment of nanoparticle accumulation after experimental brain injury: Effect of particle size. Scientific Reports 6:1.
Crossref
Crossref
Rachel Blau, Adva Krivitsky, Yana Epshtein & Ronit Satchi-Fainaro. (2016) Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?. Drug Resistance Updates 27, pages 39-58.
Crossref
Crossref
Can Sarisozen & Vladimir P. Torchilin. 2016. Drug Delivery. Drug Delivery
576
622
.
Cyril Lorenzato, Chris Oerlemans, Merel van Elk, Willie J. C. Geerts, Baudouin Denis de Senneville, Chrit Moonen & Clemens Bos. (2016) MRI monitoring of nanocarrier accumulation and release using Gadolinium-SPIO co-labelled thermosensitive liposomes. Contrast Media & Molecular Imaging 11:3, pages 184-194.
Crossref
Crossref
Stanislav Filip, Ondřej Kubeček, Jiří Špaček, Jiřina Martínková & Milan Bláha. (2016) Extracorporeal apheresis system - A nanoparticle drugs' elimination method to enhance the benefit of cytostatic therapy in cancer patients. Journal of Applied Biomedicine 14:2, pages 91-96.
Crossref
Crossref
Pier Luigi Zinzani, Vijayveer Bonthapally, Dirk Huebner, Richard Lutes, Andy Chi & Stefano Pileri. (2016) Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas. Critical Reviews in Oncology/Hematology 99, pages 228-240.
Crossref
Crossref
Cinzia Pellegrini, Roberto Maglie, Lisa Argnani, Stefano Pileri & Pier Luigi Zinzani. (2016) Impressive response to pegylated liposomal doxorubicin after allogeneic transplantation in a multi-relapsed Hodgkin's lymphoma. Hematological Oncology 34:1, pages 49-51.
Crossref
Crossref
Xiaojiao Yu, Ian Trase, Muqing Ren, Kayla Duval, Xing Guo & Zi Chen. (2016) Design of Nanoparticle-Based Carriers for Targeted Drug Delivery. Journal of Nanomaterials 2016, pages 1-15.
Crossref
Crossref
Amy M. Wen & Nicole F. Steinmetz. (2016) Design of virus-based nanomaterials for medicine, biotechnology, and energy. Chemical Society Reviews 45:15, pages 4074-4126.
Crossref
Crossref
Martin A. Philbert. 2016. Nanotechnology: Delivering on the Promise Volume 1. Nanotechnology: Delivering on the Promise Volume 1
89
95
.
Bhawani Aryasomayajula & Vladimir P. Torchilin. 2016. Nanobiomaterials in Cancer Therapy. Nanobiomaterials in Cancer Therapy
307
330
.
Roy van der Meel, Laurens J. C. Vehmeijer, Robbert Jan Kok, Gert Storm & Ethlinn V. B. van Gaal. 2016. Intracellular Delivery III. Intracellular Delivery III
163
200
.
Dalit Landesman-Milo, Shahd Qassem & Dan Peer. 2016. Nanomedicine. Nanomedicine
131
155
.
Sacha Loeve. (2015) Of drug administration, war and oïkos: mediating cancer with nanomedicines. Nanomedicine 10:21, pages 3261-3274.
Crossref
Crossref
Hongyu Zhou, Weiping Qian, Fatih M. Uckun, Liya Wang, Y. Andrew Wang, Hongyu Chen, David Kooby, Qian Yu, Malgorzata Lipowska, Charles A. Staley, Hui Mao & Lily Yang. (2015) IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer. ACS Nano 9:8, pages 7976-7991.
Crossref
Crossref
Jesus Pacheco-Torres, Nobina Mukherjee, Martin Walko, Pilar López-Larrubia, Paloma Ballesteros, Sebastian Cerdan & Armagan Kocer. (2015) Image guided drug release from pH-sensitive Ion channel-functionalized stealth liposomes into an in vivo glioblastoma model. Nanomedicine: Nanotechnology, Biology and Medicine 11:6, pages 1345-1354.
Crossref
Crossref
Lília R. Cordeiro Pedrosa, Wiggert A. van Cappellen, Barbara Steurer, Dalila Ciceri, Timo L.M. ten Hagen, Alexander M.M. Eggermont, Marcel Verheij, Felix María Goñi, Gerben A. Koning & F.-Xabier Contreras. (2015) C8-glycosphingolipids preferentially insert into tumor cell membranes and promote chemotherapeutic drug uptake. Biochimica et Biophysica Acta (BBA) - Biomembranes 1848:8, pages 1656-1670.
Crossref
Crossref
Francesca Ercole, Michael R. Whittaker, John F. Quinn & Thomas P. Davis. (2015) Cholesterol Modified Self-Assemblies and Their Application to Nanomedicine. Biomacromolecules 16:7, pages 1886-1914.
Crossref
Crossref
Leena Kumari Prasad, Hannah O'Mary & Zhengrong Cui. (2015) Nanomedicine delivers promising treatments for rheumatoid arthritis. Nanomedicine 10:13, pages 2063-2074.
Crossref
Crossref
Catherine J. Murphy, Ariane M. Vartanian, Franz M. Geiger, Robert J. Hamers, Joel Pedersen, Qiang Cui, Christy L. Haynes, Erin E. Carlson, Rigoberto Hernandez, Rebecca D. Klaper, Galya Orr & Ze’ev Rosenzweig. (2015) Biological Responses to Engineered Nanomaterials: Needs for the Next Decade. ACS Central Science 1:3, pages 117-123.
Crossref
Crossref
Liang Zhang, Zhongwei Zhang, Ralph P. Mason, Jann N. Sarkaria & Dawen Zhao. (2015) Convertible MRI contrast: Sensing the delivery and release of anti-glioma nano-drugs. Scientific Reports 5:1.
Crossref
Crossref
CAI-LING JIN, MEI-LING CHEN, YING WANG, XIAO-CHUN KANG, GUANG-YE HAN & SU-LING XU. (2015) Preparation of novel (-)-gossypol nanoparticles and the effect on growth inhibition in human prostate cancer PC-3 cells in vitro. Experimental and Therapeutic Medicine 9:3, pages 675-678.
Crossref
Crossref
Ming-Thau Sheu, Hua-Jing Jhan, Chien-Ming Hsieh, Chien-Ju Wang & Hsiu-O Ho. (2014) Efficacy of Antioxidants as a Complementary and Alternative Medicine (CAM) in Combination With the Chemotherapeutic Agent Doxorubicin. Integrative Cancer Therapies 14:2, pages 184-195.
Crossref
Crossref
Marilene Estanqueiro, Maria Helena Amaral, Jaime Conceição & José Manuel Sousa Lobo. (2015) Nanotechnological carriers for cancer chemotherapy: The state of the art. Colloids and Surfaces B: Biointerfaces 126, pages 631-648.
Crossref
Crossref
David R. KhanMaggie N. WebbThomas H. CadotteMadison N. Gavette. (2015) Use of Targeted Liposome-based Chemotherapeutics to Treat Breast Cancer. Breast Cancer: Basic and Clinical Research 9s2, pages BCBCR.S29421.
Crossref
Crossref
B. Singhana, P. Slattery & M.P. Melancon. 2015. Applications of Nanoscience in Photomedicine. Applications of Nanoscience in Photomedicine
267
290
.
Ondřej Kubeček, Milan Bláha, Daniel Diaz-Garcia & Stanislav Filip. (2015) Extracorporeal Elimination of Circulating Pegylated Liposomal Doxorubicin (PLD) to Enhance the Benefit of Cytostatic Therapy in Platinum-Resistant Ovarian Cancer Patients. Acta Medica (Hradec Kralove, Czech Republic) 58:1, pages 3-8.
Crossref
Crossref
Karolina Werengowska-Ciećwierz, Marek Wiśniewski, Artur P. Terzyk & Sylwester Furmaniak. (2015) The Chemistry of Bioconjugation in Nanoparticles-Based Drug Delivery System. Advances in Condensed Matter Physics 2015, pages 1-27.
Crossref
Crossref
Liqiong Cai, Gaofei Xu, Changying Shi, Dandan Guo, Xu Wang & Juntao Luo. (2015) Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment. Biomaterials 37, pages 456-468.
Crossref
Crossref
Kohsuke Shakushiro, Hiroki Kawano, Mari Nakata, Aya Kita, Atsushi Maeda, Shunsuke Watanabe, Kazuhiro Sako & Naoto Oku. (2014) Formulation Design and Evaluation of Liposomal Sepantronium Bromide (YM155), a Small-Molecule Survivin Suppressant, Based on Pharmacokinetic Modeling and Simulation. Pharmaceutical Research 32:1, pages 238-247.
Crossref
Crossref
Juan M. Castro, Taro Toyota & Hideo Iwasaki. 2015. Recent Advances in Natural Computing. Recent Advances in Natural Computing
113
122
.
Ethlinn V.B. van Gaal & Daan J.A. Crommelin. 2015. Non-Biological Complex Drugs. Non-Biological Complex Drugs
11
76
.
Ashish Kumar Agrawal, Dileep Urimi & Sanyog Jain. 2015. Targeted Drug Delivery : Concepts and Design. Targeted Drug Delivery : Concepts and Design
461
500
.
Angela A. Hwang, Jie Lu, Fuyuhiko Tamanoi & Jeffrey I. Zink. (2015) Functional Nanovalves on Protein-Coated Nanoparticles for In vitro and In vivo Controlled Drug Delivery. Small 11:3, pages 319-328.
Crossref
Crossref
Ka-Wing Cheng, Ting Nie, Nengtai Ouyang, Ninche Alston, Chi C. Wong, George Mattheolabakis, Ioannis Papayannis, Liqun Huang & Basil Rigas. (2014) A novel ibuprofen derivative with anti-lung cancer properties: Synthesis, formulation, pharmacokinetic and efficacy studies. International Journal of Pharmaceutics 477:1-2, pages 236-243.
Crossref
Crossref
Displaying 200 of 418 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list